USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathway
Abstract Background With the rapidly increasing morbidity and mortality, lung cancer has been considered one of the serious malignant tumors, affecting millions of patients globally. Currently, the pathogenesis of lung cancer remains unclear, hindering the development of effective treatment. This st...
Main Authors: | Lei Cao, Hongsheng Liu, Cheng Huang, Chao Guo, Luo Zhao, Chao Gao, Yuan Xu, Guige Wang, Naixin Liang, Shanqing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Biology Direct |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13062-023-00371-z |
Similar Items
-
The Mitochondrial Deubiquitinase USP30 Regulates AKT/mTOR Signaling
by: Ruohan Zhang, et al.
Published: (2022-02-01) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01) -
Expression of mTOR in normal and pathological conditions
by: A Marques-Ramos, et al.
Published: (2023-07-01) -
Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01) -
Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
by: Charles-André Philip, et al.
Published: (2017-09-01)